Hamilton Lane Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Hamilton Lane Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-56,701	Closed	-$3M	–	58
2018 Q2	$3M	Buy	56,701 +15,445	+37%	+$748K	2.73%	13
2018 Q1	$2M	Sell	41,256 -51,529	-56%	-$2.68M	1.59%	27
2017 Q4	$3.91M	Buy	92,785 +53,186	+134%	+$2.05M	2.02%	14
2017 Q3	$1.7M	Buy	+39,599	New	+$1.26M	1.17%	20
2017 Q2	–	Sell	-37,287	Closed	-$490K	–	66
2017 Q1	$490K	Buy	37,287 +15,433	+71%	+$198K	0.25%	47
2016 Q4	$283K	Buy	+21,854	New	+$337K	0.19%	54

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Hamilton Lane Advisors's MYOK Position: Q3 2018 in Review

Hamilton Lane Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2018, closing a stake of 56,701 shares — an estimated $3M sold.

Hamilton Lane Advisors first reported a position in MYOK in Q4 2016 and held it in 6 quarters. The position peaked at $3.91M in Q4 2017. 125 funds tracked by Wall St. Rank hold MYOK as of Q3 2018.

Hamilton Lane Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Hamilton Lane Advisors sold 56,701 MyoKardia, Inc. Common Stock shares in Q3 2018, an estimated $3M.
Hamilton Lane Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Hamilton Lane Advisors's MyoKardia, Inc. Common Stock position peaked at $3.91M in Q4 2017.
125 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2018.

Based on Hamilton Lane Advisors's 13F filing for Q3 2018, filed 16 Oct 2018.